References
1. Song YZ, & Deng M. (2017). Sodium taurocholate cotransporting polypeptide deficiency manifesting as cholestatic jaundice in early infancy: a complicated case study.[J]. Zhongguo Dang Dai Er Ke Za Zhi, 19(3):350–354.
2. Vaz FM. et al. (2015). Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype.[J]. Hepatology, 61(1):260–267.
3. Yan H. et al. (2014). Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.[J]. Journal of Virology, 88(6):3273–84.
4. Deng LJ. et al. (2021). Clinical characterization of NTCP deficiency in paediatric patients : A case-control study based on SLC10A1 genotyping analysis.[J]. Liver Int, 41(11): 2720-2728.
5. Hemminki K. et al. (2015). Thalassemia and sickle cell anemia in Swedish immigrants: genetic diseases have become global.[J]. SAGE open medicine. 3:2050312115613097.
6. Chong SS. et al. (2000). Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia.[J]. Blood, 95(1):360–2.
7. Lee CG, & Ki CS. (2021). A Novel De Novo Heterozygous ARID1A Missense Variant Cluster in cis c.[5954C>G;6314C>T;6334C>T;6843G>C] causes a Coffin–Siris Syndrome.[J]. Ann Lab Med, 41(3):350-353.
8. Sekiguchi F. et al. (2019). Genetic abnormalities in a large cohort of Coffin-Siris syndrome patients.[J]. J Hum Genet, 64(2):1173-86.
9. Vergano SS, & Deardorff MA. (2014). Clinical features, diagnostic criteria, and management of Coffin-Siris syndrome.[J] .Am J Med Genet C Semin Med Genet, 166(3): 252-6.
10. Lei C. (2015). Study on the intervention of Mediterranean anemia in Guangxi Zhuang Region.[J]. China Contin Med Educ, 17:27-28.
Table 1. The 2-year follow-up records of physical, blood routine and serology examination of the child.
Figure 1. A-C Sanger sequencing of exon 4 in SLC10A1 gene with the heterozygous c.800C>T (p.Ser267Phe) mutation in the heterozygous state in the proband and his mother (Red arrow). D-F Sanger sequencing of exon 1 in SLC10A1 gene with the heterozygous c.263T>C (p.lle88Thr) mutation in the heterozygous state in the proband and his father (Red arrow). G-I Sanger sequencing of exon 8 in ARID1A gene with the heterozygous c.2698G>A (p.Ala900Thr) mutation in the heterozygous state in the proband and his mother (Red arrow). J The 2-year follow-up records of growth and development, facial and the fifth digit phalanges/nails features of the child and his mother.